In tumor xenograft models of metastatic uveal melanoma, knockdown of Trio is effective at reducing tumor size and weight, suggesting inhibitor molecules targeting Trio activity could serve as effective therapeutics (7). This evidence concerns the gene TRIO and uveal melanoma.